Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Autoimmune Disease Risk With GLP‐1RA, DPP‐4i, and SGLT2i Treatment in Patients With Diabetes

Saved in:
Bibliographic Details
Published in:ACR Open Rheumatology
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1870206676897890304
collection WordPress RSS
FRELIP Feed Integration
container_title ACR Open Rheumatology
description
discipline_display Rheumatology
discipline_facet Rheumatology
format Online Article
RSS Article
genre Journal Article
id rss_article:100983
institution FRELIP
journal_source_facet ACR Open Rheumatology
last_indexed 2026-07-09T03:34:33.422Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Autoimmune Disease Risk With GLP‐1RA, DPP‐4i, and SGLT2i Treatment in Patients With Diabetes
Rheumatology
General
Rheumatology
sub_discipline_display General
sub_discipline_facet General
subject_display Rheumatology
General
Rheumatology
subject_facet Rheumatology
General
Rheumatology
title Autoimmune Disease Risk With GLP‐1RA, DPP‐4i, and SGLT2i Treatment in Patients With Diabetes
title_alt Riesgo de enfermedad autoinmune con tratamiento con GLP-1RA, DPP-4i y SGLT2i en pacientes con diabetes
Risque de maladie auto-immune avec le traitement par GLP-1RA, DPP-4i et SGLT2i chez les patients diabétiques
Risco de Doença Autoimune com Tratamento com GLP-1RA, DPP-4i e SGLT2i em Pacientes com Diabetes
title_auth Autoimmune Disease Risk With GLP‐1RA, DPP‐4i, and SGLT2i Treatment in Patients With Diabetes
title_es_txt Riesgo de enfermedad autoinmune con tratamiento con GLP-1RA, DPP-4i y SGLT2i en pacientes con diabetes
title_fr_txt Risque de maladie auto-immune avec le traitement par GLP-1RA, DPP-4i et SGLT2i chez les patients diabétiques
title_full Autoimmune Disease Risk With GLP‐1RA, DPP‐4i, and SGLT2i Treatment in Patients With Diabetes
title_fullStr Autoimmune Disease Risk With GLP‐1RA, DPP‐4i, and SGLT2i Treatment in Patients With Diabetes
title_full_unstemmed Autoimmune Disease Risk With GLP‐1RA, DPP‐4i, and SGLT2i Treatment in Patients With Diabetes
title_pt_txt Risco de Doença Autoimune com Tratamento com GLP-1RA, DPP-4i e SGLT2i em Pacientes com Diabetes
title_short Autoimmune Disease Risk With GLP‐1RA, DPP‐4i, and SGLT2i Treatment in Patients With Diabetes
title_sort autoimmune disease risk with glp‐1ra, dpp‐4i, and sglt2i treatment in patients with diabetes
topic Rheumatology
General
Rheumatology
url https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/acr2.90046?af=R